4 Result(s)
within
Tung-Shing Mamie Lih
-
Article
Open AccessUrinary marker panels for aggressive prostate cancer detection
Majority of patients with indolent prostate cancer (PCa) can be managed with active surveillance. Therefore, finding biomarkers for classifying patients between indolent and aggressive PCa is essential. In thi...
-
Article
Open AccessOptimized data-independent acquisition approach for proteomic analysis at single-cell level
Single-cell proteomic analysis provides valuable insights into cellular heterogeneity allowing the characterization of the cellular microenvironment which is difficult to accomplish in bulk proteomic analysis....
-
Article
Open AccessProteomic characterization of primary and metastatic prostate cancer reveals reduced proteinase activity in aggressive tumors
Prostate cancer (PCa) is a heterogeneous group of tumors with variable clinical courses. In order to improve patient outcomes, it is critical to clinically separate aggressive PCa (AG) from non-aggressive PCa ...
-
Article
Open AccessDevelopment of a glycoproteomic strategy to detect more aggressive prostate cancer using lectin-immunoassays for serum fucosylated PSA
Prostate-specific antigen (PSA) is commonly used as a serum biomarker for the detection of prostate cancer. However, levels of PSA in serum do not reliably distinguish aggressive prostate cancer from non-aggre...
